Mao-Lin Yan
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 36
- Hepatocellular Carcinoma Treatment and Prognosis 35
- Surgery 30
- Cholangiocarcinoma and Gallbladder Cancer Studies 26
- Co-authors
- Funan Qiu (11 shared papers)Jiayi Wu (33 shared papers)Yifeng Tian (9 shared papers)Shi Chen (9 shared papers)Jiaqiang Zhang (3 shared papers)Jiang-Zhi Chen (3 shared papers)Songqiang Zhou (9 shared papers)Yinan Li (13 shared papers)
- Journals
- Surgery (3 papers)Liver Cancer (3 papers)Annals of Surgical Oncology (3 papers)Frontiers in Oncology (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Mao-Lin Yan
49 papers receiving 725 citations
Peers
Comparison fields: 5 of 63
- Hepatology 316
- Cancer Research 228
- Oncology 224
- Pathology and Forensic Medicine 129
- Surgery 221
Countries citing papers authored by Mao-Lin Yan
This map shows the geographic impact of Mao-Lin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao-Lin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao-Lin Yan more than expected).
Fields of papers citing papers by Mao-Lin Yan
This network shows the impact of papers produced by Mao-Lin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao-Lin Yan. The network helps show where Mao-Lin Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mao-Lin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 100 | |
| 2 | 2019 | 80 | |
| 3 | 2016 | 72 | |
| 4 | 2020 | 59 | |
| 5 | 2017 | 44 | |
| 6 | 2023 | 33 | |
| 7 | 2005 | 33 | |
| 8 | 2022 | 33 | |
| 9 | 2022 | 22 | |
| 10 | 2020 | 20 | |
| 11 | 2007 | 18 | |
| 12 | 2021 | 17 | |
| 13 | 2023 | 16 | |
| 14 | 2018 | 16 | |
| 15 | 2023 | 11 | |
| 16 | 2023 | 10 | |
| 17 | Postoperative complications after liver transplantation with cavoportal hemitransposition. | 2008 | 10 |
| 18 | 2020 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2021 | 8 |
About Mao-Lin Yan
Mao-Lin Yan is a scholar working on Hepatology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 61 papers that have together received 726 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers), Renal cell carcinoma treatment (11 papers), Cancer Mechanisms and Therapy (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer, Lipids, and Metabolism (6 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hepatology (316 citations), Cancer Research (228 citations), Oncology (224 citations), Pathology and Forensic Medicine (129 citations) and Surgery (221 citations). Mao-Lin Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Funan Qiu, Jiayi Wu, Yifeng Tian, Shi Chen, Jiaqiang Zhang, Jiang-Zhi Chen, Songqiang Zhou, Yinan Li, Jianyin Zhou and Yufeng Chen. Their work appears in journals such as Surgery, Liver Cancer, Annals of Surgical Oncology, Frontiers in Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.